Oxidative refolding of amyloidogenic variants of human lysozyme

Journal of Molecular Biology

Volumn 351, Issue 3, 2005, Pages 662-671

  Wain, Rachel ^a,c   Smith, Lorna J ^a   Dobson, Christopher M ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Amyloidogenic disease; Disulphide bonds; Human lysozyme; Protein refolding

Indexed keywords

ASPARTYLHISTIDINE; ISOLEUCYLTHREONINE; LYSOZYME; PROTEIN; UNCLASSIFIED DRUG;

AMYLOIDOSIS; ARTICLE; DISULFIDE BOND; ENZYME RELEASE; MUTATION; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN FOLDING; REACTION ANALYSIS; WILD TYPE;

EID: 22544457182     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2005.06.035     Document Type: Article

References (32)

1. M.B. Pepys, P.N. Hawkins, D.R. Booth, D.M. Vigushin, G.A. Tennent, and A.K. Soutar Human lysozyme gene mutations cause hereditary systemic amyloidosis Nature 362 1993 553 557
2. S. Valleix, S. Drunat, J.B. Philit, D. Adoue, J.C. Piette, and D. Droz Hereditary renal amyloidosis caused by a new variant lysozyme W64R in a French family Kidney Int. 61 2002 907 912
3. M. Yazaki, S.A. Farrell, and M.D. Benson A novel lysozyme mutation Phe57Ile associated with hereditary renal amyloidosis Kidney Int. 63 2003 1652 1657
4. D.R. Booth, M. Sunde, V. Bellotti, C.V. Robinson, W.L. Hutchinson, and P.E. Fraser Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis Nature 385 1997 787 793
5. D. Canet, M. Sunde, A.M. Last, A. Miranker, A. Spencer, C.V. Robinson, and C.M. Dobson Mechanistic studies of the folding of human lysozyme and the origin of amyloidogenic behavior in its disease-related variants Biochemistry 38 1999 6419 6427
6. D. Canet, A.M. Last, P. Tito, M. Sunde, A. Spencer, and C. Redfield The solution dynamics of amyloidogenic Asp67His variant of human lysozyme: insights from hydrogen exchange Biophys. J. 78 2000 22Plat
7. M. Dumoulin, A.M. Last, A. Desmyter, K. Decanniere, D. Canet, and G.R. Larsson A camelid antibody fragment inhibits the formation of amyloid fibrils by human lysozyme Nature 424 2003 783 788
8. M. Dumoulin, D. Canet, A.M. Last, E. Pardon, D.B. Archer, and S. Muyldermans Reduced global cooperativity is a common feature underlying the amyloidogenicity of pathogenic lysozyme mutations J. Mol. Biol. 346 2005 773 788
9. C.M. Dobson Protein folding and its links with human disease Biochem. Soc. Symp. 68 2001 1 26
10. D. Canet, K. Doering, C.M. Dobson, and Y. Dupont High-sensitivity fluorescence anisotropy detection of protein-folding events: application to alpha-lactalbumin Biophys. J. 80 2001 1996 2003
11. S.D. Hooke, S.E. Radford, and C.M. Dobson The refolding of human lysozyme: a comparison with the structurally homologous hen lysozyme Biochemistry 33 1994 5867 5876
12. J. Funahashi, K. Takano, K. Ogasahara, Y. Yamagata, and K. Yutani The structure, stability, and folding process of amyloidogenic mutant human lysozyme J. Biochem. (Tokyo) 120 1996 1216 1223
13. A. Helenius Quality control in the secretory assembly line Phil. Trans. Roy. Soc. ser. B 356 2001 147 150
14. B. van den Berg, E.W. Chung, C.V. Robinson, and C.M. Dobson Characterisation of the dominant oxidative folding intermediate of hen lysozyme J. Mol. Biol. 290 1999 781 796
15. P. van den Berg, E.W. Chung, C.V. Robinson, P.L. Mateo, and C.M. Dobson The oxidative refolding of hen lysozyme and its catalysis by protein disulfide isomerase EMBO J. 18 1999 4794 4803
16. Wain, R. (2003). Studies of protein folding and aggregation. D.Phil. University of Oxford.
17. G.L. Ellman Tissue sulfhydryl groups Arch. Biochem. Biophys. 82 1959 70 77
18. P. Roux, M. Delepierre, M.E. Goldberg, and A.F. Chaffotte Kinetics of secondary structure recovery during the refolding of reduced hen egg white lysozyme J. Biol. Chem. 272 1997 24843 24849
19. Y. Taniyama, K. Ogasahara, K. Yutani, and M. Kikuchi Folding mechanism of mutant human lysozyme C77/95a with increased secretion efficiency in yeast J. Biol. Chem. 267 1992 4619 4624
20. K. Inaka, Y. Taniyama, M. Kikuchi, K. Morikawa, and M. Matsushima The crystal-structure of a mutant human lysozyme-C77/95a with increased secretion efficiency in yeast J. Biol. Chem. 266 1991 12599 12603
21. G.V. Semisotnov, N.A. Rodionova, O.I. Razgulyaev, V.N. Uversky, A.F. Gripas, and R.I. Gilmanshin Study of the molten globule intermediate state in protein folding by a hydrophobic fluorescent-probe Biopolymers 31 1991 119 128
22. J.S. Weissman, and P.S. Kim Reexamination of the folding of BPTI - predominance of native intermediates Science 253 1991 1386 1393
23. Y. Taniyama, Y. Yamamoto, R. Kuroki, and M. Kikuchi Evidence for difference in the roles of 2 cysteine residues involved in disulfide bond formation in the folding of human lysozyme J. Biol. Chem. 265 1990 7570 7575
24. Y. Taniyama, Y. Yamamoto, M. Nakao, M. Kikuchi, and M. Ikehara Role of disulfide bonds in folding and secretion of human lysozyme in Saccharomyces cerevisiae Biochem. Biophys. Res. Commun. 152 1988 962 967
25. P.J. Artymiuk, and C.C.F. Blake Refinement of human lysozyme at 1.5 a resolution: analysis of non-bonded and hydrogen-bond interactions J. Mol. Biol. 152 1981 737 762
26. B. Kundu, N.R. Maiti, E.M. Jones, K.A. Surewicz, D.L. Vanik, and W.K. Surewicz Nucleation-dependent conformational conversion of the Y145Stop variant of human prion protein: structural clues for prion propagation Proc. Natl Acad. Sci. USA 100 2003 12060 12074
27. L.J. Smith, K.M. Fiebig, H. Schwalbe, and C.M. Dobson The concept of a random coil. Residual structure in peptides and denatured proteins Fold. Des. 1 1996 95 106
28. H. Schwalbe, K.M. Fiebig, M. Buck, J.A. Jones, S.B. Grimshaw, and A. Spencer Structural and dynamical properties of a denatured protein. Heteronuclear 3D NMR experiments and theoretical simulations of lysozyme in 8 M urea Biochemistry 36 1997 8977 8991
29. O.B. Ptitsyn Molten globule and protein folding Advan. Protein Chem. 47 1995 83 229
30. A.K. Chamberlain, V. Receveur, A. Spencer, C. Redfield, and C.M. Dobson Characterization of the structure and dynamics of amyloidogenic variants of human lysozyme by NMR spectroscopy Protein Sci. 10 2001 2525 2530
31. A. Spencer, L.A. Morozov-Roche, W. Noppe, D.A. MacKenzie, D.J. Jeenes, and M. Joniau Expression, purification, and characterization of the recombinant calcium-binding equine lysozyme secreted by the filamentous fungus Aspergillus niger: comparisons with the production of hen and human lysozymes Protein Expr. Purif. 16 1999 171 180
32. D. Shugar The measurement of lysozyme activity and the ultra-violet inactivation of lysozyme Biochim. Biophys. Acta 8 1952 302 309